1.Zhang Yulin, Zhang Y, Fang Z, Ni S. China's chikungunya virus outbreak is a wake-up call.Nature. 2025 Sep;645(8079):41.(IF=55，一作兼通讯)
2.Han X, Feng F, Wang Z, Huang S, Xi K, Fang Z, Shen J, Wang M, Zhang Y, Liu B, Wang J, Wang J, Liang X, Sun G, Zhang R, Han B, Liu F, Li M, Zhang X, Wang J, Geng H, Zhang Y, Zhang W, Wu Z, Li X, Li Y, Cheng L,Zhang Yulin, Ni S. Preventing Glioblastoma Relapse by Igniting Innate Immunity through Mitochondrial Stress in the Surgical Cavity.Advanced Materials.2025 Sep 8:e11351.(IF=28.9，共同通讯)
3.Cheng L, Fang Z, Wang J, Xi K, Zhang Y, Feng F, Yu L, Santiago M, Wang J, Wu Z, Wang KN, Daubon T, Ni S, Zhang Y,Zhang Yulin. Mitochondrial inflexibility ignites tumor immunogenicity in postoperative glioblastoma.Nature Communications.2025 Jul 28;16(1):6946.(IF=16.6，最后通讯)
4.Liu Z, Chen C,Zhang Yulin, Ji F, Liu H, Du H, Guo Y, Dong X, Yang Z, Han M, Tang C, Yang K, Zhang J, Zhao K, Chen Y, Jiang X, Xu F. Legumain In Situ Engineering Promotes Efferocytosis of CAR Macrophage to Treat Cardiac Fibrosis.Advanced Materials. 2025 Jul;37(27):e2417831.(IF=28.9，共同一作)
5.Shao L, Zhang Y, Yang Z, Shi C, Yue X, Li C, Liu Y, Fu Z, Tang C, Zhao X, Han M, Zhang J, Sun W, Yao Z, Xi K, Fang Z, Wang Z, Feng F, Ma C, Zhao K,Zhang Yulin, Ni S, Jiang X, Chen C. Synthetic efferocytic receptor microglia enhances anti-inflammatory clearance of amyloid-β for AD treatment in mice.Science Advances. 2025 Jul 11;11(28):eads6613.(IF=14.1，共同通讯)
6.Zhang Yulin,Fang Z, Liu Z, Xi K, Zhang Y, Zhao D, Feng F, Geng H, Liu M, Lou J, Chen C, Zhang Y, Wu Z, Xu F, Jiang X, Ni S. Implantable Microneedle-Mediated Eradication of Postoperative Tumor Foci Mitigates Glioblastoma Relapse.Advanced Materials.2024 Oct;36(40):e2409857.(IF=30.2，一作兼通讯)
7.Zhang Yulin, Xi K, Fu Z, Zhang Y, Cheng B, Feng F, Dong Y, Fang Z, Zhang Y, Shen J, Wang M, Han X, Geng H, Sun L, Li X, Chen C, Jiang X, Ni S. Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse.Nature Communications. 2024 May 18;15(1):4241.(IF=16.6，一作)
8.Zhang Yulin, Xi K, Zhang Y, Fang Z, Zhang Y, Zhao K, Feng F, Shen J, Wang M, Zhang R, Cheng B, Geng H, Li X, Huang B, Wang KN, Ni S. Blood-Brain Barrier Penetrating Nanovehicles for Interfering with Mitochondrial Electron Flow in Glioblastoma.ACS Nano. 2024 Mar 18. Epub ahead of print. PMID: 38499440.(IF=17.1，一作)
9.Zhang Yulin, Xi K, Fu X, Sun H, Wang H, Yu D, Li Z, Ma Y, Liu X, Huang B, Wang J, Li G, Cui J, Li X, Ni S. Versatile metal-phenolic network nanoparticles for multitargeted combination therapy and magnetic resonance tracing in glioblastoma.Biomaterials.2021 Nov; 278:121163.(IF=15.3，一作)
10.Feng F, Shen J, Qi Q,Zhang Yulin, Ni S. Empowering brain tumor management: chimeric antigen receptor macrophage therapy.Theranostics. 2024 Sep 3;14(14):5725-5742.(IF=13.1)
11.Fu, X.*,Zhang Yulin*, Zhang, G., Li, X., Ni, S., & Cui, J. (2022). Targeted delivery of Fenton reaction packages and drugs for cancer theranostics.Applied Materials Today, 26, 101353.(IF=8.3，共同第一)
12.Zhang Yulin, Kong Y, Ma Y, Ni S, Wikerholmen T, Xi K, Zhao F, Zhao Z, Wang J, Huang B, Chen A, Yao Z, Han M, Feng Z, Hu Y, Thorsen F, Wang J, Li X. Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines.Oncogene. 2021 Feb;40(8):1425-1439.(IF=9.3，一作)
13.Zhang Yulin, Fu X, Jia J, Wikerholmen T, Xi K, Kong Y, Wang J, Chen H, Ma Y, Li Z, Wang C, Qi Q, Thorsen F, Wang J, Cui J, Li X, Ni S. Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles.ACS Appl Mater Interfaces. 2020 Sep 30;12(39):43408-43421.(IF=9.2，一作)
14.Wang, S. *,Zhang Yulin*, Sun, F., Xi, K., Sun, Z., Zheng, X., ... & Sun, L. (2023). Catalase-like nanozymes combined with hydrogel to facilitate wound healing by improving the microenvironment of diabetic ulcers.Materials & Design, 225, 111557.(IF=8.4，共同第一)
